Dmitry Balyasny’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Dmitry Balyasny's XBI Position: Q3 2026 in Review
Dmitry Balyasny opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 13,704 shares worth $2.16M. The stake represents ﹤0.01% of the portfolio and ranks #1834 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in XBI as recently as Q4 2025.
Dmitry Balyasny first reported a position in XBI in Q2 2015 and has held it in 20 quarters since. The position peaked at $57.2M in Q3 2019. 962 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Dmitry Balyasny held 13,704 shares of State Street SPDR S&P Biotech ETF worth $2.16M as of Q3 2026.
- State Street SPDR S&P Biotech ETF was a new Dmitry Balyasny position in Q3 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1834 holding.
- Dmitry Balyasny first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 20 quarters since.
- Dmitry Balyasny's State Street SPDR S&P Biotech ETF position peaked at $57.2M in Q3 2019.
- 962 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.